Atlas FDA

Atellica IM Alpha Fetoprotein (AFP)

FDA premarket approval P930036/S024 · decided 2024-09-23

Approval details

PMA number
P930036
Supplement
S024
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Atellica IM Alpha Fetoprotein (AFP)
Generic name
KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS
Applicant
Siemens Healthcare Diagnostics, Inc.
Date received
2024-06-25
Decision date
2024-09-23
Days to decision
90 days
Decision code
APPR
Product code
LOK
Advisory committee
Immunology
Expedited review
No
Location
East Walpole, MA
Statement
placement of Atellica IM assay onto the Atellica CI Analyzer with Atellica Sample Handler configuration.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Atellica CH Acetaminophen 2 (ACTM) (K261364)Siemens Healthcare Diagnostics, Inc.2026-07-24
Atellica CH Diazo Total Bilirubin (D_TBil) (K251998)Siemens Healthcare Diagnostics, Inc.2026-02-27
Atellica® IM TSH3-Ultra II (TSH3ULII) (K251543)Siemens Healthcare Diagnostics, Inc.2026-02-06
Atellica IM Total PSA II (tPSAII) (K251630)Siemens Healthcare Diagnostics, Inc.2026-01-05
ADVIA Centaur Anti-Thyroglobulin II (aTgII) (K250816)Siemens Healthcare Diagnostics, Inc.2025-12-04
ADVIA Centaur Anti-Thyroid Peroxidase II (K250250)Siemens Healthcare Diagnostics, Inc.2025-10-17
Atellica IM Thyroglobulin (Tg) (K242981)Siemens Healthcare Diagnostics, Inc.2025-06-20
Atellica® CH Creatinine_3 (Crea3) (K242685)Siemens Healthcare Diagnostics, Inc.2024-12-04